Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Glycylglycine Market size is set to register remarkable growth rate during the forecast period i.e., between 2025-2037.
The growth of the market can be attributed to the increasing application of glycylglycine in healthcare and cosmetic industries. In healthcare, glycylglycine is used as a metabolite, and in research activities related to treatment of colorectal cancer, cystic fibrosis, and prostate cancer. In turn, the growing investment in the medical R&D activities is estimated to drive the growth of the market. As per the data by the World Bank, 2.203% of the global gross domestic product (GDP) was spent on R&D activities in 2018. In addition to this, glycylglycine is also intensively used in the cosmetic industry for manufacturing hair and skin conditioners. The increasing adoption of organic chemicals for production of cosmetics and other personal goods is estimated to boost the market growth. Moreover, the surging import and export of chemicals across the globe, backed by the growth of the chemical sector, is further likely to propel the demand for glycylglycine during the forecast period.
Glycylglycine is a dipeptide formed from glycine residues, which has a varied pH range of 2.5–3.8 and 7.5–8.9. Owing to its pH range and low toxicity, it is used as a buffer for biological systems, especially metabolic activities. It is considered as the simplest of all peptides, and is used for improvement in protein solubility after cell lysis.
Glycylglycine Sector: Growth Drivers and Challenges
Growth Drivers
- Increasing Application in the Healthcare and Cosmetics Sector
- Growing Research and Development Activities
Challenges
- Unstable for Storage Once Dissolved
- Disrupted Supply of Raw Material
Glycylglycine Segmentation
The market is segmented by application into pharmaceutical, organic chemicals, cosmetics, bio-chemical research, and others. Out of these, the cosmetics segment is anticipated to hold a substantial revenue share in the global glycylglycine market over the forecast period on account of increasing demand for organic products among consumers. On the other hand, the pharmaceutical segment is foreseen to gain noteworthy growth during the forecast period, owing to the growth in research and development activities, and high investment in the healthcare sector.
Our in-depth analysis of the global market includes the following segments:
By Purity |
|
By Application |
|
By End-User |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportGlycylglycine Industry - Regional Synopsis
On the basis of geographical analysis, the global glycylglycine market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in Europe industry is poised to hold largest revenue share by 2036, on the back of growth in the number of researchers in the region. Moreover, the growing import of chemicals in the region is also estimated to boost the market growth. According to the data by the International Trade Center (ITC), Germany and France imported chemical products worth USD 22,631,592 and USD 11,652,675 respectively in 2021.
The market in the North America region is anticipated to gain the largest market share throughout the forecast period owing to the increasing presence of major chemical manufacturing companies, along with increasing medical research activities in the region.

Companies Dominating the Glycylglycine Landscape
- Bio Basic Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Carl Roth Gmbh & Co. Kg
- SIELC Technologies, Inc.
- Poly Harmony International Co. Ltd.
- VWR International, LLC.
- Capot Chemical Co. Ltd.
- Hangzhou Keying Chem Co., Ltd
- Krackeler Scientific, Inc.
- Merck Group
- Alfa Aesar (Thermo Fisher Scientific)
In the News
-
April 05, 2022: Merck Group, a leading science and technology company, to complete the acquisition of the MAST (Modular Automated Sampling Technology) platform from Lonza.
-
June 23, 2017: Thermo Fisher Scientific completed the acquisition of Affymetrix, including its USB Biochemicals products.
Author Credits: Rajrani Baghel
- Report ID: 4048
- Published Date: Dec 24, 2024
- Report Format: PDF, PPT